EUVIMEDEUVIMED entdecken
FallberichtOpen Access

When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF :: PHF1 fusion

Aarti E Sharma, Josephine K Dermawan, Andy E Sherrod, Shefali Chopra, Robert G Maki, Cristina R Antonescu iD

Genes, Chromosomes and Cancer · 2024

DOI: 10.1002/gcc.23206 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Aarti E Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Fibroma, Ossifying, Fibroma, Sarcoma, Osteosarcoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present two cases of malignant ossifying fibromyxoid tumor (OFMT) which eluded diagnosis due to compelling clinicopathologic mimicry, compounded by similarly elusive underlying molecular drivers. The first is of a clavicle mass in a 69 year‐old female, which histologically showed an infiltrative nested and trabeculated proliferation of monomorphic cells giving rise to scattered spicules of immature woven bone. Excepting SATB2 positivity, the lesion showed an inconclusive immunoprofile which along with negative PHF1 FISH led to an initial diagnosis of high‐grade osteosarcoma. Next generation sequencing (NGS) revealed a particularly rare CREBBP::BCORL1 fusion. The second illustrates the peculiar presentation of a dural‐based mass in a 52 year‐old female who presented with neurologic dyscrasias. Sections showed a sheeted monotonous proliferation of ovoid to spindle cells, but in contrast to Case #1, the tumor contained an exuberance of reticular osteoid and woven bone deposition mimicking malignant osteogenic differentiation. NGS showed a novel CREBZF::PHF1 fusion. Both tumors recurred locally less than 1 year post‐operatively. As such we reiterate that careful morphologic examination is axiomatic to any diagnosis in our discipline, but this paradigm must shift to recognize that molecular diagnostics can provide closure where traditional tools have notable limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroma, OssifyingFibromaSarcomaOsteosarcomaBone NeoplasmsSoft Tissue NeoplasmsFemaleHumansAgedMiddle AgedDNA-Binding ProteinsOsteogenesisPolycomb-Group ProteinsNeoplasm Recurrence, LocalBasic-Leucine Zipper Transcription Factors

Stichwörter der Autor:innen

BCORBCORL1CREBBP1CREBZF1PHF1fusionmalignant ossifying fibromyxoid tumorosteosarcoma

Substanzen

DNA-Binding ProteinsPolycomb-Group ProteinsPHF1 protein, humanCREBZF protein, humanBasic-Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, New York, USA.
  • Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
  • Department of Medicine, Sarcoma Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Cristina R Antonescu

Förderung

  • NCI NIH HHS

Zitieren

APA

Sharma, A. E., Dermawan, J. K., Sherrod, A. E., Chopra, S., Maki, R. G., & Antonescu, C. R. (2024). When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF :: PHF1 fusion. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23206

Vancouver

Sharma AE, Dermawan JK, Sherrod AE, Chopra S, Maki RG, Antonescu CR. When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF :: PHF1 fusion. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23206

BibTeX
@article{Sharma2024,
  author = {Sharma, Aarti E and Dermawan, Josephine K and Sherrod, Andy E and Chopra, Shefali and Maki, Robert G and Antonescu, Cristina R},
  title = {When molecular outsmarts morphology: Malignant ossifying fibromyxoid tumors masquerading as osteosarcomas, including a novel CREBZF :: PHF1 fusion},
  journal = {Genes, Chromosomes and Cancer},
  year = {2024},
  doi = {10.1002/gcc.23206}
}
Kostenlos starten →